BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Ovarian cancer AND ALK, CD246, ENSG00000171094, 238, Q9UM73, TFG/ALK AND Prognosis
20 results:

  • 1. Prognostic value of alk overexpression and molecular abnormalities in high-grade serous ovarian carcinoma.
    Gorczyński A; Miszewski K; Gager Y; Koch S; Pötschke J; Ugrinovski D; Gabert J; Pospieszyńska A; Wydra D; Duchnowska R; Szymanowski B; Cierniak S; Kruecken I; Neumann K; Mirkov K; Biernat W; Czapiewski P
    Cancer Biomark; 2023; 38(1):17-26. PubMed ID: 37522200
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. [Expression and significance of immune checkpoint B7-homolog 4 in endometrial cancer].
    Zong LJ; Xiang Y; Yu SN; Lu ZH; Chen J; Huang WH
    Zhonghua Fu Chan Ke Za Zhi; 2022 Dec; 57(12):921-931. PubMed ID: 36562226
    [No Abstract]    [Full Text] [Related]  

  • 3. Somatic genomic landscape of East Asian epithelial ovarian carcinoma and its clinical implications from prospective clinical sequencing: A Korean Gynecologic Oncology Group study (KGOG 3047).
    Sa JK; Kim J; Kang S; Kim SW; Song T; Shim SH; Choi MC; No JH; Song JY; Kim D; Kim YM; Kim JH; Lee JW
    Int J Cancer; 2022 Oct; 151(7):1086-1097. PubMed ID: 35666535
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. [Clinical analysis of 23 cases with simultaneous double primary gynecological malignant tumors].
    He Y; Wang Y; Ji C; Liu Y; Wu YM
    Zhonghua Fu Chan Ke Za Zhi; 2022 May; 57(5):352-360. PubMed ID: 35658326
    [No Abstract]    [Full Text] [Related]  

  • 5. Better or worse? The prognostic role of the mesenchymal subtype in patients with high-grade serous ovarian carcinoma: A systematic review and meta-analysis.
    Chen J; Shi X; Xiao L; Li Z; Li Z; Sun L
    Cancer Med; 2022 Oct; 11(20):3761-3770. PubMed ID: 35434908
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Risk factors and prognostic implications of diagnosis of cancer within 30 days after an emergency hospital admission (emergency presentation): an International cancer Benchmarking Partnership (ICBP) population-based study.
    McPhail S; Swann R; Johnson SA; Barclay ME; Abd Elkader H; Alvi R; Barisic A; Bucher O; Clark GRC; Creighton N; Danckert B; Denny CA; Donnelly DW; Dowden JJ; Finn N; Fox CR; Fung S; Gavin AT; Gomez Navas E; Habbous S; Han J; Huws DW; Jackson CGCA; Jensen H; Kaposhi B; Kumar SE; Little AL; Lu S; McClure CA; Møller B; Musto G; Nilssen Y; Saint-Jacques N; Sarker S; Te Marvelde L; Thomas RS; Thomas RJS; Thomson CS; Woods RR; Zhang B; Lyratzopoulos G;
    Lancet Oncol; 2022 May; 23(5):587-600. PubMed ID: 35397210
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Anaplastic Lymphoma Kinase Overexpression Is Associated with Aggressive Phenotypic Characteristics of ovarian High-Grade Serous Carcinoma.
    Matsumoto T; Oda Y; Hasegawa Y; Hashimura M; Oguri Y; Inoue H; Yokoi A; Tochimoto M; Nakagawa M; Jiang Z; Saegusa M
    Am J Pathol; 2021 Oct; 191(10):1837-1850. PubMed ID: 34214505
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Prognostic and Theranostic Biomarkers in ovarian Clear Cell Carcinoma.
    Wiedemeyer K; Wang L; Kang EY; Liu S; Ou Y; Kelemen LE; Feil L; Anglesio MS; Glaze S; Ghatage P; Nelson GS; Köbel M
    Int J Gynecol Pathol; 2022 Mar; 41(2):168-179. PubMed ID: 33770057
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Population-based estimates of survival among elderly patients with brain metastases.
    Lamba N; Kearney RB; Catalano PJ; Hassett MJ; Wen PY; Haas-Kogan DA; Aizer AA
    Neuro Oncol; 2021 Apr; 23(4):661-676. PubMed ID: 33068418
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Pure pediatric ovarian immature teratomas: The French experience.
    Pavone R; Dijoud F; Galmiche L; Ro V; Hameury F; Sarnacki S; Orbach D; Briandet C; Pasquet M; Bertrand A; Fresneau B; Faure-Conter C
    Pediatr Blood Cancer; 2020 Apr; 67(4):e28186. PubMed ID: 31981415
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. High expression of mesothelin in advanced serous ovarian cancer is associated with poor prognosis.
    Yildiz Y; Kabadayi G; Yigit S; Kucukzeybek Y; Alacacioglu A; Varol U; Taskaynatan H; Salman T; Oflazoglu U; Akyol M; Tarhan MO
    J BUON; 2019; 24(4):1549-1554. PubMed ID: 31646807
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. alk rearrangement: a high-frequency alteration in ovarian metastasis from lung adenocarcinoma.
    Bi R; Bai Q; Zhu X; Tu X; Cai X; Jiang W; Xu X; Tang S; Ge H; Chang B; Cheng Y; Gan H; Zhou X; Yang W
    Diagn Pathol; 2019 Aug; 14(1):96. PubMed ID: 31455365
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Expression of RRBP1 in epithelial ovarian cancer and its clinical significance.
    Ma J; Ren S; Ding J; Liu S; Zhu J; Ma R; Meng F
    Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31285390
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Comprehensive analysis of PD-L1 expression, HER2 amplification, alk/EML4 fusion, and mismatch repair deficiency as putative predictive and prognostic factors in ovarian carcinoma.
    Schmoeckel E; Hofmann S; Fromberger D; Rottmann M; Luthardt B; Burges A; Jeschke U; Kirchner T; Lax SF; Mayr D
    Virchows Arch; 2019 May; 474(5):599-608. PubMed ID: 30734108
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Successful maintenance therapy with apatinib inplatinum-resistant advanced ovarian cancer and literature review.
    Jin M; Cai J; Wang X; Zhang T; Zhao Y
    Cancer Biol Ther; 2018; 19(12):1088-1092. PubMed ID: 30110192
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Aberrant Expression of Anaplastic Lymphoma Kinase in ovarian Carcinoma Independent of Gene Rearrangement.
    Tang S; Yang F; Du X; Lu Y; Zhang L; Zhou X
    Int J Gynecol Pathol; 2016 Jul; 35(4):337-47. PubMed ID: 27271776
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Splenectomy in the context of primary cytoreductive operations for advanced epithelial ovarian cancer.
    Eisenkop SM; Spirtos NM; Lin WC
    Gynecol Oncol; 2006 Feb; 100(2):344-8. PubMed ID: 16202446
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.
    Casey MJ; Synder C; Bewtra C; Narod SA; Watson P; Lynch HT
    Gynecol Oncol; 2005 May; 97(2):457-67. PubMed ID: 15863145
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. [Prognostic factors and better survival rate after the treatment of advanced ovarian cancer with neoadjuvant chemotherapy].
    Ivanov S; Ivanov S; Khadzhiolov N
    Akush Ginekol (Sofiia); 2004; 43(6):17-9. PubMed ID: 15669647
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. [Combined CA-125 test and ultrasonography in the presurgical evaluation of ovarian mass].
    Chiu SW; Ho SC; Hung YC; Lee YH
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1991 Aug; 7(8):429-34. PubMed ID: 1875465
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.